Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04992897 · ClinicalTrials.gov registry record
Real-world Data Analysis of REN Treatment in Migraine Patients
A clinical trial, sponsored by Theranica.
- Completed
- Registry status
- 12,151
- Enrollment target
NCT04992897 is a clinical trial that has completed, run by Theranica. The registered enrollment target is 12,151 participants.
The verdict
NCT04992897 has completed, sponsored by Theranica.
- COMPLETED
- Registry status
- 12,151 participants
- Enrollment target
Study Summary
Data analysis concerning four sets of metrics: A. Per-treatment patterns of REN use as a standalone treatment vs. in combination with medications. B. Per-user Intra-individual consistency of efficacy across multiple treatments (consistency defined as a response to treatment in at least 50% of treatments). C. Distribution of treatment intensity among users (the electroceutical equivalent to treatment dose). D. Prevalence and severity of adverse events.
Interventions
- DEVICE Remote Electrical Neuromodulation (REN)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12,151 participants |
| Start Date | 2021-06-15 |
| Est. Completion | 2021-08-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04992897
The ClinicalTrials.gov registry entry for NCT04992897 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 12,151 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Theranica, which has 22 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Remote Electrical Neuromodulation (REN) is the first listed.
NCT04992897 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04992897 about?
NCT04992897 is a clinical study titled "Real-world Data Analysis of REN Treatment in Migraine Patients". Data analysis concerning four sets of metrics: A. Per-treatment patterns of REN use as a standalone treatment vs. in combination with medications. B. Per-user Intra-individual consistency of efficacy across multiple treatments (consistency defined as a response to treatment in at least 50% of treatm...
What is the current status of trial NCT04992897?
This trial is currently completed. The enrollment target is 12,151 participants. The study started on 2021-06-15. Estimated completion is 2021-08-10.
What interventions are being tested in trial NCT04992897?
The interventions under investigation include: Remote Electrical Neuromodulation (REN) (DEVICE).
Who is sponsoring clinical trial NCT04992897?
This trial is sponsored by Theranica, which has 22 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.